<!DOCTYPE html>
<html lang="en" xmlns="http://www.w3.org/1999/html">
<head>
    <meta charset="UTF-8">
    <title>醫療選項簡介</title>
    <link rel="stylesheet" href="style/background.css">
    <link rel="stylesheet" href="style/content.css">
    <link rel="stylesheet" href="style/medical_option.css">
    <link rel="stylesheet" href="style/menu.css">
    <link rel="stylesheet" href="style/page_top.css">
    <link rel="stylesheet" href="style/clickhint_button.css">
    <link rel="icon" href="resources/favicon.ico" type="image/x-icon"/>
</head>
<body>
<div class="menu" onclick="window.open('dictionary.html', '_self')">
    <img class="menu-logo" src="resources/menu.png" alt="回首頁"/>
</div>

<div class="page_top step1">HER2陽性藥物<br>選擇「單標靶」或「雙標靶」</div>

<span class="paragraph point">化學治療</span>
<div class="option_box">
    <div class="option">
        <span class="paragraph">主要用來停止癌細胞的生長或直接破壞癌細胞。能有效殺死癌細胞，但同時也會影響生長中的正常細胞，進而產生副作用。</span>
        <span class="paragraph detail">治療療程為每三個星期一次，根據腫瘤縮小狀況預計執行<span class="number">6-8</span>次</span>
    </div>
    <img src="resources/therapy/opt_chemistry.png" class="option_img" alt="化學治療">
</div>
<hr/>

<span class="paragraph point">單標靶治療</span>
<div class="option_box">
    <div class="option">
        <span class="paragraph">「<span class="highlight">賀癌平</span>」是一種針對乳癌HER2基因過度表現的藥物，可與癌細胞中的HER2結合，阻止腫瘤細胞生長與分化，進而死亡。</span>
        <span class="paragraph detail"><span class="highlight">賀癌平</span>目前健保給付條件是腋下淋巴結有轉移，腋下淋巴沒有轉移需要自費</span>
        <span class="paragraph detail">治療療程為每三個星期一次共一年(<span class="number">18</span>次)</span>
    </div>
    <img src="resources/therapy/opt_single.png" class="option_img" alt="單標靶治療">
</div>
<hr/>

<span class="paragraph point">雙標靶治療</span>
<div class="option_box">
    <div class="option">
        <span class="paragraph"><span class="highlight highlight2">雙標靶藥物</span>是除了「<span
                class="highlight">賀癌平</span>」外再加上「<span class="highlight">賀疾妥</span>」的治療，可加強阻斷HER2癌細胞生長訊息傳導，使癌細胞停止生長，進而死亡。對於高復發風險之HER2陽性淋巴結有轉移的早期乳癌病患，更能降低復發風險。</span>
        <span class="paragraph detail">「<span
                class="highlight">賀疾妥</span>」目前健保沒有給付，需要自費。目前還有結合「<span
                class="highlight">賀癌平</span>」與「<span class="highlight">賀疾妥</span>」的皮下注射劑型「<span
                class="highlight">賀雙妥</span>」，也需要自費。</span>
        <span class="paragraph detail">治療療程為每三個星期一次共一年(<span class="number">18</span>次)</span>
    </div>
    <img src="resources/therapy/opt_dual.png" class="option_img" alt="雙標靶治療">
</div>

<hr class="bar"/>
<div class="paragraph highlight warming">無論是單標靶還是雙標靶都需要搭配化學治療</div>
<hr class="bar"/>

<span class="paragraph point">術後輔助治療：<br>賀癌寧Kadcyla</span>
<div class="option_box">
    <div class="option">
        <div class="description">
            <img src="resources/therapy/opt_after.png" alt="雙標靶治療">
        </div>
        <span class="paragraph"><span class="highlight">賀癌寧</span>是將化療藥物與<span class="highlight">賀癌平</span>結合在一起的標靶藥物</span>
        <span class="paragraph">當<span class="highlight">賀癌寧</span>進入HER2陽性癌細胞體內才會釋放出化療藥物</span>
        <span class="paragraph">既可以有效殺死癌細胞，也可以使化療藥物對正常細胞的傷害降到最低。</span>
        <span class="paragraph">HER2陽性乳癌經歷術前輔助治療，但手術後病理報告顯示仍有殘餘癌細胞者，術後改用<span
                class="highlight">賀癌寧</span>治療，可以再降低<span class="number">48%</span>的復發風險。</span>
    </div>
</div>
<div class="button_block">
    <button onclick="window.open('understanding.html', '_self')">了解您的想法</button>
    <div class="click_hint content_button next"></div>
</div>
</body>
</html>